glp -1 patch Why GLP-1 Patches Don't Deliver—Yet GLP-1 Patches: Do They Work?

If you have any questions or concerns, please don't hesitate to reach out to us

A population-based cohort study of nearly 114,000 patients with T2D found that use of GLP-1s, compared with SGLT-2 inhibitors, was associated with a 27% higher relative risk of being diagnosed with GERD and a 55% higher relative risk of GERD-related complications

From the approval of Orlistat (Xenical) in 1999, which focused on reducing dietary fat absorption, to the emergence of highly effective incretin-based therapies such as liraglutide (Saxenda), semaglutide (Wegovy), and tirzepatide (Zepbound), we have witnessed a fundamental shift in how obesity is understood and treated

Notably, the $500 range is also the amount manufacturers offer for self-pay obesity patients, raising important questions about whether these programs are truly benefiting those who need them most5,6